192 related articles for article (PubMed ID: 22031668)
1. MicroRNAs in chromosomal translocation-associated solid tumors: learning from sarcomas.
Dela Cruz F; Matushansky I
Discov Med; 2011 Oct; 12(65):307-17. PubMed ID: 22031668
[TBL] [Abstract][Full Text] [Related]
2. Searching for molecular targets in sarcoma.
Teicher BA
Biochem Pharmacol; 2012 Jul; 84(1):1-10. PubMed ID: 22387046
[TBL] [Abstract][Full Text] [Related]
3. Advances in chromosomal translocations and fusion genes in sarcomas and potential therapeutic applications.
Xiao X; Garbutt CC; Hornicek F; Guo Z; Duan Z
Cancer Treat Rev; 2018 Feb; 63():61-70. PubMed ID: 29247978
[TBL] [Abstract][Full Text] [Related]
4. Sarcomas: genetics, signalling, and cellular origins. Part 2: TET-independent fusion proteins and receptor tyrosine kinase mutations.
Suvà ML; Cironi L; Riggi N; Stamenkovic I
J Pathol; 2007 Oct; 213(2):117-30. PubMed ID: 17703479
[TBL] [Abstract][Full Text] [Related]
5. Sarcomas: genetics, signalling, and cellular origins. Part 1: The fellowship of TET.
Riggi N; Cironi L; Suvà ML; Stamenkovic I
J Pathol; 2007 Sep; 213(1):4-20. PubMed ID: 17691072
[TBL] [Abstract][Full Text] [Related]
6. The Biology of Ewing sarcoma.
Riggi N; Stamenkovic I
Cancer Lett; 2007 Aug; 254(1):1-10. PubMed ID: 17250957
[TBL] [Abstract][Full Text] [Related]
7. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.
Stegmaier S; Leuschner I; Aakcha-Rudel E; Münch P; Kazanowska B; Bekassy A; Treuner J; Koscielniak E
Klin Padiatr; 2004; 216(6):315-22. PubMed ID: 15565546
[TBL] [Abstract][Full Text] [Related]
8. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M
Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028
[TBL] [Abstract][Full Text] [Related]
9. Assessment of molecular genetic detection of chromosome translocations in the differential diagnosis of pediatric sarcomas.
Dockhorn-Dworniczak B; Schäfer KL; Blasius S; Christiansen H; Koscielniak E; Ritter J; Winkelmann W; Jürgens H; Böcker W
Klin Padiatr; 1997; 209(4):156-64. PubMed ID: 9293447
[TBL] [Abstract][Full Text] [Related]
10. Translocation-related sarcomas.
Mertens F; Antonescu CR; Hohenberger P; Ladanyi M; Modena P; D'Incalci M; Casali PG; Aglietta M; Alvegård T
Semin Oncol; 2009 Aug; 36(4):312-23. PubMed ID: 19664492
[TBL] [Abstract][Full Text] [Related]
11. Combinatorial strategies to potentiate the efficacy of HDAC inhibitors in fusion-positive sarcomas.
Lanzi C; Cassinelli G
Biochem Pharmacol; 2022 Apr; 198():114944. PubMed ID: 35152144
[TBL] [Abstract][Full Text] [Related]
12. Identification of altered MicroRNA expression patterns in synovial sarcoma.
Hisaoka M; Matsuyama A; Nagao Y; Luan L; Kuroda T; Akiyama H; Kondo S; Hashimoto H
Genes Chromosomes Cancer; 2011 Mar; 50(3):137-45. PubMed ID: 21213367
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal translocations in sarcomas: prospects for therapy.
Tomescu O; Barr FG
Trends Mol Med; 2001 Dec; 7(12):554-9. PubMed ID: 11733218
[TBL] [Abstract][Full Text] [Related]
14. Chromosome translocations in sarcomas and the emergence of oncogenic transcription factors.
Xia SJ; Barr FG
Eur J Cancer; 2005 Nov; 41(16):2513-27. PubMed ID: 16213703
[TBL] [Abstract][Full Text] [Related]
15. Targeting the undruggable: exploiting neomorphic features of fusion oncoproteins in childhood sarcomas for innovative therapies.
Knott MML; Hölting TLB; Ohmura S; Kirchner T; Cidre-Aranaz F; Grünewald TGP
Cancer Metastasis Rev; 2019 Dec; 38(4):625-642. PubMed ID: 31970591
[TBL] [Abstract][Full Text] [Related]
16. Pediatric sarcomas: translating molecular pathogenesis of disease to novel therapeutic possibilities.
Anderson JL; Denny CT; Tap WD; Federman N
Pediatr Res; 2012 Aug; 72(2):112-21. PubMed ID: 22546864
[TBL] [Abstract][Full Text] [Related]
17. Ewing sarcoma with novel translocation t(2;16) producing an in-frame fusion of FUS and FEV.
Ng TL; O'Sullivan MJ; Pallen CJ; Hayes M; Clarkson PW; Winstanley M; Sorensen PH; Nielsen TO; Horsman DE
J Mol Diagn; 2007 Sep; 9(4):459-63. PubMed ID: 17620387
[TBL] [Abstract][Full Text] [Related]
18. Laboratory investigation, genetics, and experimental models in sarcomas.
Fletcher JA
Curr Opin Oncol; 1991 Aug; 3(4):665-70. PubMed ID: 1932225
[TBL] [Abstract][Full Text] [Related]
19. Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma.
Riggi N; Cironi L; Provero P; Suvà ML; Stehle JC; Baumer K; Guillou L; Stamenkovic I
Cancer Res; 2006 Jul; 66(14):7016-23. PubMed ID: 16849546
[TBL] [Abstract][Full Text] [Related]
20. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma.
Kawai A; Woodruff J; Healey JH; Brennan MF; Antonescu CR; Ladanyi M
N Engl J Med; 1998 Jan; 338(3):153-60. PubMed ID: 9428816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
